Pediatric Psoriatic Arthritis

Joint symptom relief is possible for pediatric patients

SKYRIZI is approved for children and teens (ages 6+) with active psoriatic arthritis

If you are dealing with active psoriatic arthritis (PsA) for your child, or yourself, you are not alone.

If you are dealing with active psoriatic arthritis (PsA) for your child, or yourself, you are not alone.

Early recognition, diagnosis, and treatment of PsA is important

PsA symptoms often appear during the early years. Delaying treatment, even by as little as six months, can result in permanent joint damage. 

No daily dosing

Only 4 doses a year, after 2 starter doses

Each dose of SKYRIZI consists of either a 55 mg/0.37 mL or a 150 mg/mL injection. The actual dose your child receives is dependent on their weight.

55 mg/0.37 mL pre-filled syringe
for pediatric patients 6+ who weigh less than 88 lbs (40 kg)

OR

150 mg/mL pre-filled pen (or syringe)
for pediatric patients 6+ who weigh 88 lbs (40 kg) or more or for adults

Administering SKYRIZI

Injections can be administered at home or in a doctor's office. 

  • For pediatric patients 6 to less than 10 years of age, SKYRIZI should be administered by an adult
  • For pediatric patients 10 years of age and older, it is recommended that SKYRIZI be administered by or under the supervision of an adult
  • Caregivers and children 10 and older should be trained on how to inject by a healthcare professional

Learn more about how to inject SKYRIZI

2 starter doses in week 1 and week 4. After, doses are in weeks 16, 28, 40, and 52, yearly.

Ways to make the administration environment more comfortable for children

Caregivers may also want to create a comfortable environment for children or teens (ages 6 and older). Some ideas include:

Breathing techniques

Emotional support stuffed animals or blankets

Using a reward system

Find out how you can get help paying for SKYRIZI

Learn about ways to save